Skip to content

In vivo study comparing gastric emptying and small intestine distribution of a glucose solution in the fasting and postprandial state

In vivo study comparing gastric emptying and small intestine distribution of a glucose solution in the fasting and postprandial state - MRI_Glucose

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037562
Enrollment
12
Registered
2025-07-29
Start date
2025-07-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric emptying and small intestine distribution in healthy subjects

Interventions

Group 1: Ingestion of a manganese-labeled 10% glucose solution on an empty stomach and monitoring of gastric emptying and small intestine distribution using MRI. Group 2: Ingestion of a manganese-labe

Sponsors

Universität Greifswald
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Age: 18–55 years old Gender: Male and female BMI: between 18 kg/m² and 30 kg/m² Good health, assessed by the investigator as not deviating from the norm in clinical terms. Written informed consent form available.

Exclusion criteria

Exclusion criteria: Disorders/diseases affecting the swallowing process (e.g., severe dysphagia related to food and/or solid oral dosage forms) Claustrophobia Gastrointestinal disorders and/or pathological changes that could interfere with gastric emptying Known or suspected stenosis, fistulas, or mechanical obstructions within the gastrointestinal tract Liver disorders Surgical procedures on the gastrointestinal tract within the last 12 months Inflammatory bowel diseases (Crohn's disease, ulcerative colitis, or diverticulitis) Implanted or portable electromechanical medical devices such as pacemakers, defibrillators, or infusion pumps Large dark tattoos Known allergies or intolerances to the components of the fluids Alcohol or drug addiction Smokers who consume more than 10 cigarettes per day Eating disorders such as anorexia or bulimia Positive pregnancy test or pregnancy People who are known to be unwilling or unable to follow instructions reliably Persons who are unable to understand written and verbal instructions and instructions regarding the risks of the study Less than 14 days after acute illness Systemic use of medication, especially medication that affects the function of the gastrointestinal tract Simultaneous participation in interventional research projects; the interval since previous participation in other studies should not be less than 14 days

Design outcomes

Secondary

MeasureTime frame
Training of an artificial intelligence for automated segmentation of the stomach and small intestine.

Primary

MeasureTime frame
Dependence of gastric emptying and small intestine distribution of a glucose solution in the fasting versus postprandial state.

Countries

Germany

Contacts

Public ContactWerner Weitschies

Universität Greifswald

werner.weitschies@uni-greifswald.de+49 3834 4204813

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026